![]() |
![]() |
![]() |
|
Vol. 10, Nos 1-24, pp. 1-616 Jan. 4 - Dec. 20, 2010 A | B | C | D | E | F | G | H | I | J | K | L | M | N | O | P | Q | R | S | T | U | V | W | X | Y | Z
PATENTS
– Biotechnology, expert reports held to high standards, 564
– Damages
– – Hypothetical negotiations-based calculations
– – – Allowed (Fed. Cir.), 311
– – – Reasonableness, Daubert analysis of expert testimony, 608 – Extra-sweet pineapples, selective facts testimony inadmissible (2d Cir.), 557 – Infringement, jury acted within discretion in crediting prior art expert (Fed. Cir.), 209 – Legal malpractice, failure to conduct prior art search or patentability analysis (Fed. Cir.), 107 – Royalty damages, failure to link licensing to infringement dooms claim (Fed. Cir.), 118
– Air pollution, vinyl chloride discharges, average exposure determination and cancer cluster failure to show classwide exposure (E.D. Pa.), 144
– Asbestos occupational exposure re smoking as cause of pleural thickening (Pa.), 389 – Design defects, malfunction theory of vending machine fire, testimony based on speculation improper (E.D. Pa.), 66 – Pharmaceuticals, Prempro-caused breast cancer, jury rejects causation testimony (Pa. C.P.), 116 – Qualifications, psychiatric injuries, psychiatric nurse practitioner qualified (M.D. Pa.), 315 – Work product doctrine yield to discovery of expert communications (Pa. Super. Ct.), 486
See CHEMICALS
– Accutane
– – Failure to warn, expert's study not following own methodology unreliable (N.J. Super. Ct.), 81
– – Inflammatory bowel disease, statistical proof on incidence in general public (N.J. Super. Ct.), 414 – Baycol-caused muscle damage, failure to rule out alternatives (8th Cir.), 133 – Bendectin to vaccine-caused autism, evolving judicial scrutiny, practitioner analysis, 237 – Biotechnology, expert reports held to high standards, 564 – Disclosure, FDA proposed expansion of application and clinical findings information, misuse potential, 451 – Fentanyl patch, spectrometry test of blood goes to weight (Tex. App.), 202 – Fosamax, bone jaw disorder
– – Causation expert testimony (S.D.N.Y.), 83
– – Inconclusive proof prompts dismissal (2d Cir.), 556 – Levaquin, ghostwriting of expert and scientific literature, evidence admissible (D. Minn.), 557 – Metoclopramide-caused tardive dyskinesia, treating physician general causation testimony fails to establish (S.D. W.Va.), 605 – Minocycline-caused vision loss, warning labels, expert admission concerning adequacy sufficient to deny summary judgment (M.D. Ga.), 164 – Motrin-caused blindness, exclusion of label with expert's handwritten warning suggestions proper (Cal. App. Ct.), 533 – Neurotin
– – Lethargy and disorientation, expert refusal to link drug dooms suit (D. Mass.), 449
– – Suicide, off-label use, economist testimony on marketing allowed, testimony of FDA worker involved in drug application allowed (M.D. Tenn.), 228 – Phenylpropanolamine-caused neurological illness, methodology fails Daubert (Iowa), 105 – Prempro-caused breast cancer, jury rejects testimony (Pa. C.P.), 116 – Provera, Premarin, and Prempro, trial court failure to perform Daubert analysis, drugmakers seek review (U.S., rev sought), 279; (rev den), 343 – Requip, linking to gambling fails (5th Cir.), 161 – Seroquel-caused diabetes, testimony barred for failure to consider alternative causes (11th Cir.), 191 – Trasylol labeling, regulatory expert testimony on unilateral update of label barred (S.D. Fla.), 534 – Tylenol, cirrhosis of the liver, failure to prove causation (N.Y. Sup. Ct.), 63 – Zyprexa litigation, confidential documents, permanent injunction bars disclosure (2d Cir.), 437
– Attorney misrepresentation of finding, claims against law firm (E.D. Pa.), 560
– CAT scan interpretation, medical expert need not have same credentials as preparer of source material (Ind. App. Ct.), 413 – Controlled substances, over prescribing, admission of video showing proper patient exams harmless error (6th Cir.), 10 – Disciplinary proceedings
– – Consulting medical expert testimony not admissible (Tex. App.), 259
– – Investigative records ordered subject to discovery (Fla. Dist. Ct. App.), 487
– – Anesthesiologist, epidural steroid injections, recent and relevant experiences satisfy Va. clinical practice requirement (E.D. Va.), 312
– – Animal feed antibiotic link to injuries beyond treating physician expertise (N.M. Ct. App.), 515 – – Cardiac treatment, certified cardiologists qualified (Tex. App.), 166 – – Cardiologist testimony on physician assistant standard of care (Tenn.), 358 – – Community standards knowledge – – Neurologist with head trauma experience qualified testify on obstetrician/gynecologist standard of care re hematoma-caused injury (Tex. App.), 599 – – Pharmacist not barred from testifying on standard of care (D.S.D.), 252 – – Practice of same specialty not required (D. Md.), 582 – – Pre-suit certificate, waiver of board certification in same specialty (N.J.), 383 – – Testimony of hospital former chief surgeon improperly excluded (Del.), 466 – – Thoracic certified surgeon never performing specific procedure (Tex. App.), 511 – – Vascular surgeon qualified to address kidney damage (Tex. App.), 552 – – Vertebroplasty, radiologist practicing substantially same specialty (Mo.), 362
– – Animal feed antibiotic link to injuries beyond treating physician expertise (N.M. Ct. App.), 515
– – Back injury, orthopedic surgeon barred from expressing opinion on effect of work-related vibrations on condition (E.D. Okla.), 286 – – Causation testimony subject to same rules as retained experts (8th Cir.), 513 – – Expert report required where causation opinion not determined at time of treatment (7th Cir.), 463 – – Lay testimony status requires knowledge and opinions obtained through course of treatment (S.D.), 110 – – Metoclopramide-caused tardive dyskinesia, general causation testimony fails to establish (S.D. W.Va.), 605 – – Vocational rehabilitation expert opinion of fitness for work rejected in favor of treating physician (5th Cir.), 231 – – Work product doctrine yield to discovery of expert communications (Pa. Super. Ct.), 486
– Age discrimination, class actions, failure to establish commonality and or use well accepted methodology (N.D. Cal.), 471
– Controlled substances, visual identification insufficient (N.C. Ct. App.), 534 – Drunk driving field sobriety test, Frye standards applicability to opinion of officer (Kan.), 363 – Excessive use of force claim, former officer testimony not relevant (2d Cir.), 363 – Motor vehicle accident, opinion on speed (Mass. App. Ct.), 445
See ENVIRONMENT
– Regulatory compliance defense, analysis, 268
– Discovery, e-mails inadvertently sent to expert required to be disclosed (S.D. Ohio), 108
– E-mail retrieval of personal messages to attorney on company laptop violated privacy right (N.J.), 193 – Inadvertent waivers, analysis of court rulings on Fed. R. Evid. 502, 94 – NIH peer-review data, privilege recognized (D. Del.), 281 – Zyprexa litigation, confidential documents, permanent injunction bars disclosure (2d Cir.), 437
– Continuance motion, denial not equivalent to exclusion of expert (Ga.), 552
– Bicycle carbon-fiber fork defect, testimony of aircraft-coating expert not conducting tests speculative (2d Cir.), 227
– Boiler repair, metallurgist qualifications, lack of practical experience not bar (5th Cir.), 532 – Class actions
– – Conclusive ruling on admissibility required at certification stage (7th Cir.), 201
– – Daubert considerations at pre-certification stage, analysis, 348 – Design defects
See DESIGN DEFECTS
– Discovery sanctions, water heater gas control, reports from nontestifying experts in settled cases not basis (Ind. App. Ct.), 225 – Escalator accident, res ipsa loquitur barred by causation options (5th Cir.), 280 – Gas can explosion, evaporation rate of aged gasoline, unknown error rate and lack of literature not bar (D. Utah), 554 – Halogen lamp fire, failure to address alternative theories (Tex.), 339 – Hydraulic lift platform failure, expert need not address product misuse (Ill. Ct. App.), 315 – Medical devices
See MEDICAL DEVICES
See MOTOR VEHICLES
– Oil rig wire rope sling, parts maker entitled to directed verdict (Tex. App.), 367 – Pharmaceuticals
See PHARMACEUTICALS
– Power tool warning sufficiency, font size, guesswork disallowed (Cal. Ct. App.), 495 – Scientific literature use, challenging peer-reviewed material, practitioner discussion, 397 – Timex watch straps, hexavalent chromium-caused dermatitis, untimely report rejected, conclusory report not stating relevant standards rejected (W.D. La.), 62 Contact the Webmaster at webmaster@bna.com Copyright © The Bureau of National Affairs, Inc. All Rights Reserved. |